CERI, CEFX, and CPI: Largely improved positive controls for testing antigen‐specific T cell function in PBMC compared to CEF

9Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Monitoring antigen‐specific T cell immunity relies on functional tests that require T cells and antigen presenting cells to be uncompromised. Drawing of blood, its storage and shipment from the clinical site to the test laboratory, and the subsequent isolation, cryopreservation and thawing of peripheral blood mononuclear cells (PBMCs) before the actual test is performed can introduce numerous variables that may jeopardize the results. Therefore, no T cell test is valid without as-sessing the functional fitness of the PBMC being utilized. This can only be accomplished through the inclusion of positive controls that actually evaluate the performance of the antigen‐specific T cell and antigen presenting cell (APC) compartments. For Caucasians, CEF peptides have been com-monly used to this extent. Moreover, CEF peptides only measure CD8 cell functionality. We introduce here universal CD8+ T cell positive controls without any racial bias, as well as positive controls for the CD4+ T cell and APC compartments. In summary, we offer new tools and strategies for the assessment of PBMC functional fitness required for reliable T cell immune monitoring.

Cite

CITATION STYLE

APA

Lehmann, A. A., Reche, P. A., Zhang, T., Suwansaard, M., & Lehmann, P. V. (2021). CERI, CEFX, and CPI: Largely improved positive controls for testing antigen‐specific T cell function in PBMC compared to CEF. Cells, 10(2), 1–12. https://doi.org/10.3390/cells10020248

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free